Literature DB >> 18316340

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Lesley Wood1, Matthias Egger, Lise Lotte Gluud, Kenneth F Schulz, Peter Jüni, Douglas G Altman, Christian Gluud, Richard M Martin, Anthony J G Wood, Jonathan A C Sterne.   

Abstract

OBJECTIVE: To examine whether the association of inadequate or unclear allocation concealment and lack of blinding with biased estimates of intervention effects varies with the nature of the intervention or outcome.
DESIGN: Combined analysis of data from three meta-epidemiological studies based on collections of meta-analyses. DATA SOURCES: 146 meta-analyses including 1346 trials examining a wide range of interventions and outcomes. MAIN OUTCOME MEASURES: Ratios of odds ratios quantifying the degree of bias associated with inadequate or unclear allocation concealment, and lack of blinding, for trials with different types of intervention and outcome. A ratio of odds ratios <1 implies that inadequately concealed or non-blinded trials exaggerate intervention effect estimates.
RESULTS: In trials with subjective outcomes effect estimates were exaggerated when there was inadequate or unclear allocation concealment (ratio of odds ratios 0.69 (95% CI 0.59 to 0.82)) or lack of blinding (0.75 (0.61 to 0.93)). In contrast, there was little evidence of bias in trials with objective outcomes: ratios of odds ratios 0.91 (0.80 to 1.03) for inadequate or unclear allocation concealment and 1.01 (0.92 to 1.10) for lack of blinding. There was little evidence for a difference between trials of drug and non-drug interventions. Except for trials with all cause mortality as the outcome, the magnitude of bias varied between meta-analyses.
CONCLUSIONS: The average bias associated with defects in the conduct of randomised trials varies with the type of outcome. Systematic reviewers should routinely assess the risk of bias in the results of trials, and should report meta-analyses restricted to trials at low risk of bias either as the primary analysis or in conjunction with less restrictive analyses.

Mesh:

Year:  2008        PMID: 18316340      PMCID: PMC2267990          DOI: 10.1136/bmj.39465.451748.AD

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

Authors:  L McAuley; B Pham; P Tugwell; D Moher
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

Review 3.  Allocation concealment and blinding: when ignorance is bliss.

Authors:  Peta M Forder; Val J Gebski; Anthony C Keech
Journal:  Med J Aust       Date:  2005-01-17       Impact factor: 7.738

4.  Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study.

Authors:  Lorenzo P Moja; Elena Telaro; Roberto D'Amico; Ivan Moschetti; Laura Coe; Alessandro Liberati
Journal:  BMJ       Date:  2005-04-07

Review 5.  Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.

Authors:  Julie Pildal; An-Wen Chan; Asbjørn Hróbjartsson; Elisabeth Forfang; Douglas G Altman; Peter C Gøtzsche
Journal:  BMJ       Date:  2005-04-07

Review 6.  Bias in clinical intervention research.

Authors:  Lise Lotte Gluud
Journal:  Am J Epidemiol       Date:  2006-01-27       Impact factor: 4.897

7.  The GATE frame: critical appraisal with pictures.

Authors:  Rod Jackson; Shanthi Ameratunga; Joanna Broad; Jennie Connor; Anne Lethaby; Gill Robb; Sue Wells; Paul Glasziou; Carl Heneghan
Journal:  Evid Based Med       Date:  2006-04

8.  Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trials.

Authors:  V Siersma; B Als-Nielsen; W Chen; J Hilden; L L Gluud; C Gluud
Journal:  Stat Med       Date:  2007-06-30       Impact factor: 2.373

9.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

10.  Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.

Authors:  P J Devereaux; B J Manns; W A Ghali; H Quan; C Lacchetti; V M Montori; M Bhandari; G H Guyatt
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

View more
  709 in total

1.  A randomized controlled trial of the plastic-housing BioSand filter and its impact on diarrheal disease in Copan, Honduras.

Authors:  Anna M Fabiszewski de Aceituno; Christine E Stauber; Adam R Walters; Rony E Meza Sanchez; Mark D Sobsey
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

Review 2.  Interferon alpha for chronic hepatitis D.

Authors:  Zaigham Abbas; Muhammad Arsalan Khan; Mohammad Salih; Wasim Jafri
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

3.  Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.

Authors:  Nat M J Wright; Laura Sheard; Clive E Adams; Bruno J Rushforth; Wendy Harrison; Nicole Bound; Roger Hart; Charlotte N E Tompkins
Journal:  Br J Gen Pract       Date:  2011-12       Impact factor: 5.386

4.  How to read a clinical trial paper: a lesson in basic trial statistics.

Authors:  Shail M Govani; Peter D R Higgins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

5.  Evidence-based mechanistic reasoning.

Authors:  Jeremy Howick; Paul Glasziou; Jeffrey K Aronson
Journal:  J R Soc Med       Date:  2010-11       Impact factor: 5.344

Review 6.  Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.

Authors:  Rahul S Koti; Kurinchi S Gurusamy; Giuseppe Fusai; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

7.  Causal inference methods to study nonrandomized, preexisting development interventions.

Authors:  Benjamin F Arnold; Ranjiv S Khush; Padmavathi Ramaswamy; Alicia G London; Paramasivan Rajkumar; Prabhakar Ramaprabha; Natesan Durairaj; Alan E Hubbard; Kalpana Balakrishnan; John M Colford
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

Review 8.  The use of follicle flushing during oocyte retrieval in assisted reproductive technologies: a systematic review and meta-analysis.

Authors:  Gary Levy; Micah J Hill; Christina I Ramirez; Luiz Correa; Mary E Ryan; Alan H DeCherney; Eric D Levens; Brian W Whitcomb
Journal:  Hum Reprod       Date:  2012-05-30       Impact factor: 6.918

Review 9.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

Review 10.  Inconsistency in the items included in tools used in general health research and physical therapy to evaluate the methodological quality of randomized controlled trials: a descriptive analysis.

Authors:  Susan Armijo-Olivo; Jorge Fuentes; Maria Ospina; Humam Saltaji; Lisa Hartling
Journal:  BMC Med Res Methodol       Date:  2013-09-17       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.